Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia
To read more please click on the link below.
Read Article
Related Articles
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Improvement in quality of life after asfotase alfa treatment in adults with pediatric-onset hypophosphatasia: data from 5 patient-reported outcome measures
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Physical Function and Health‐Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric‐Onset Hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Long-term effectiveness of asfotase alfa in adults with pediatric-onset hypophosphatasia in routine clinical practice
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Responses